Bone Biologics Growth Metrics (2016-2017) | BBLG

Growth Metrics Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017
Growth Ratios
Assets Growth (1y) -60.75%-62.79%116.30%
Assets (QoQ) -45.99%-66.95%-9.11%141.87%-48.79%92.14%
Cash & Equivalents Growth (1y) -61.80%-64.32%135.67%
Cash & Equivalents (QoQ) -48.02%-68.64%-9.86%159.90%-51.44%107.15%
Cash from Operations Growth (1y) 60.11%59.08%62.75%26.51%
Cash from Operations (QoQ) 19.79%25.69%15.82%20.49%17.73%32.35%-66.07%
EBITDA Margin Growth (1y) -265279.00-141114.00-97427.00
EBITDA Margin (QoQ) -173136.00-13968.00-48971.0029,718.00-100.00
EBIT Growth (1y) 76.27%145.55%70.69%57.92%
EBIT Margin Growth (1y) -265279.00-141114.00-97427.00
EBIT Margin (QoQ) -173136.00-13968.00-48971.0029,718.00-100.00
EBIT (QoQ) 52.37%11.04%19.27%30.64%191.43%-157.26%-15.90%
EBT Growth (1y) 76.17%121.68%43.70%41.06%
EBT Margin Growth (1y) -357105.00-141114.00-97427.00
EBT Margin (QoQ) -264963.00-13968.00-48971.0029,718.00-100.00
EBT (QoQ) 61.70%10.15%-11.36%37.80%134.83%-333.40%-16.58%
Enterprise Value Growth (1y) 61.80%64.32%-135.67%
Enterprise Value (QoQ) 48.02%68.64%9.86%-159.90%51.44%-107.15%
EPS (Basic) Growth (1y) 78.50%316.67%-454.55%-468.67%
EPS (Basic) (QoQ) 65.71%8.33%-13.50%39.72%445.44%-334.62%-16.39%
EPS (Weighted Average and Diluted) Growth (1y) 303.11%
FCF Margin Growth (1y) -68271.00-47651.00-37079.00
FCF Margin (QoQ) -25178.00-14730.00-4557.00-4159.001,879.00
Free Cash Flow Growth (1y) 60.11%59.08%62.75%26.51%
Free Cash Flow (QoQ) 19.79%25.69%15.82%20.49%17.73%32.35%-66.07%
Interest Coverage Ratio Growth (1y) 90.35%117.13%91.47%
Interest Coverage Ratio (QoQ) 58.97%11.59%172.83%-144.02%1.10%
Net Cash Flow Growth (1y) -68.06%59.08%155.70%-1,273.01%
Net Cash Flow (QoQ) -165.25%25.69%95.49%1,561.82%-183.60%201.16%-211.05%
Net Income Growth (1y) 76.17%121.64%43.71%41.05%
Net Income (QoQ) 61.71%10.12%-11.32%37.80%134.77%-333.76%-16.58%
Net Income towards Common Stockholders Growth (1y) 76.17%121.64%43.71%41.05%
Net Income towards Common Stockholders (QoQ) 61.71%10.12%-11.32%37.80%134.77%-333.76%-16.58%
Net Margin Growth (1y) -357157.00-141097.00-97455.00
Net Margin (QoQ) -265014.00-13941.00-48955.0029,702.00-100.00
Operating Income Growth (1y) 76.27%145.55%70.69%57.92%
Operating Income (QoQ) 52.37%11.04%19.27%30.64%191.43%-157.26%-15.90%
Operating Margin Growth (1y) -265279.00-141114.00-97427.00
Operating Margin (QoQ) -173136.00-13968.00-48971.0029,718.00-100.00
Profit After Tax Growth (1y) 76.17%121.64%43.71%41.05%
Profit After Tax (QoQ) 61.71%10.12%-11.32%37.80%134.77%-333.76%-16.58%
Property, Plant & Equipment (Net) Growth (1y) -39.78%-39.75%-39.72%
Property, Plant & Equipment (Net) (QoQ) -11.05%-12.42%-14.18%-9.92%-11.01%-12.37%
Return on Assets (QoQ) 2,135.00536.00136.00
Return on Capital Employed (QoQ) -480.00-1676.00-337.00
Return on Equity (QoQ) -134.00-80.00-33.00
Return on Invested Capital (QoQ) 39.00
Return on Sales Growth (1y) -3572.00-1411.00-975.00-2317.00
Return on Sales (QoQ) -2650.00-139.001,342.00-2124.00-490.00297.00-1.00
Revenue Growth (1y) -145.85%-165.92%-243.75%
Revenue (QoQ) -16.07%-0.63%-25.54%-30.08%-17.19%
Share-based Compensation Growth (1y) -45.08%-47.71%-63.27%-82.60%
Share-based Compensation (QoQ) 9.73%-1.47%20.53%-57.86%4.47%-30.79%-42.91%
Shareholder's Equity Growth (1y) -143.29%-79.93%-46.24%
Shareholder's Equity (QoQ) -66.70%-29.44%-20.16%6.16%-23.29%-5.20%
Tax Rate (QoQ) 3.00
Total Debt Growth (1y) 34.34%
Total Debt (QoQ) -41.44%114.54%1.51%5.34%